<DOC>
	<DOC>NCT03029000</DOC>
	<brief_summary>A, multi-center, open-label, single-arm clinical study to assess effects of a 5-day regimen of 10 Î¼g/kg of tbo-filgrastim administered sc daily on the mobilization of CD34+ cells in at least 60 healthy male and female donors. The pharmacokinetics, pharmacodynamics, safety, tolerability, and immunogenicity of tbo-filgrastim will be assessed .</brief_summary>
	<brief_title>Study of the Effect of a 5-day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy Donors</brief_title>
	<detailed_description />
	<mesh_term>Lenograstim</mesh_term>
	<criteria>The donor has a BW between 50 and 120 kg, inclusive. The donor has a BMI of more than 18.5 and less than 30.0 kg/m2. The donor is in good health Additional criteria apply, please contact the investigator for more information The donor currently has or had a history of any clinically relevant gastrointestinal, hematologic, respiratory, psychiatric, renal, hepatic, cardiac, metabolic (eg, fructose intolerance), neurological, or any other disease or condition which may influence the physiological metabolic turnover (eg, severe endocrine diseases, febrile condition, severe infections The donor has had: (1) a trauma or surgery in the past 2 months The donor has existence or recent history of persistent pulmonary infiltrates, recent pneumonia, recent bronchitis, recurrent lung infections, or history or evidence of any lung disease including asthma, or current symptoms of upper respiratory tract infection The donor has a history of malignancy, including hematologic malignancy, except for appropriately treated nonmelanoma skin carcinoma in the last 5 years. The donor is pregnant or lactating, or was pregnant in the previous 6 months, or intends to get pregnant during the study or within 30 days after the last dose of study drug The donor has donated plasma within 7 days before screening or has donated blood within 56 days before screening. The donor has a documented or selfreported history of tuberculosis or recent travel to countries of endemic disease (last 8 weeks) Additional criteria apply, please contact the investigator for more information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>